Results 71 to 80 of about 22,491 (233)

Clinical Behaviour and Outcome of Pelvic Osteosarcoma in Dogs: A Retrospective Multicentre Analysis of 74 Cases (2007–2025)

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 4, Page 819-829, December 2026.
ABSTRACT Although osteosarcoma is the most common primary bone tumour in dogs, involvement of the pelvic bones is rare. The aim of the present study was to describe clinical presentation, identify possible prognostic factors, and evaluate outcomes in dogs diagnosed with pelvic osteosarcoma.
Csilla Fejös   +15 more
wiley   +1 more source

Effects of ionizing radiation on schedule-induced polydipsia [PDF]

open access: yes, 2003
The aim of the present work was to explore and evaluate the effects of ionizing radiation on schedule-induced polydipsia. Five food deprived rats were used as subjects and submitted to baseline procedure, after that they were divided in two experimental ...
Lincoln da Silva Gimenes   +5 more
core   +1 more source

Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome

open access: yesScientific Reports, 2021
The aim of this study was to correlate three commercially available copeptin assays and their diagnostic accuracy in the differential diagnosis of the polyuria-polydipsia syndrome.
Clara Odilia Sailer   +6 more
doaj   +1 more source

Efficacy and Field Safety of the Second‐Generation, Highly Selective JAK1 Inhibitor Atinvicitinib for the Treatment of Canine Atopic Dermatitis: A Multicentre, Blinded, Randomised, Placebo‐Controlled Clinical Trial in Client‐Owned Dogs

open access: yesVeterinary Dermatology, Volume 37, Issue 6, Page 916-923, December 2026.
Background: Janus kinase (JAK) inhibitors alleviate pruritus and clinical signs of canine atopic dermatitis (cAD). Objective: To confirm the optimal dosing regimen of atinvicitinib, a second‐generation highly selective inhibitor of JAK1 in dogs. Conclusions and Clinical Relevance: Once‐daily atinvicitinib was safe, well‐tolerated and effective at ...
Faris Jirjis   +6 more
wiley   +1 more source

Primary polydipsia: A case report

open access: yes, 2013
Primary polydipsia (PP) is etiologically associated with physical factors and psychiatric disorders ("psychogenic polydipsia"). We present the case of a 28-year-old man with severe symptoms of polydipsia and polyuria.
Michopoulos, I.   +8 more
core   +1 more source

PSİKOJENİK POLİDİPSİNİN NEDEN OLDUĞU BİR HİPONATREMİK ENSEFALOPATİ OLGUSU

open access: yesCerrahpaşa Medical Journal, 2014
Background.- In psychiatric diseases excessive water drinking in a short time is known as psychogenic polydipsy. In this instance water can not be excreted from kidneys, which leads to water intoxication complicated with severe neurological findings and ...
Ayten CEYHAN DİRİCAN   +6 more
doaj  

STRESS AND POLYDIPSIA

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Psychogenic polydipsia is an uncommon clinical disorder and seen as so much drinking without physiological stimuli. Atrial natriuretic peptide (ANP) is related with ACTH, ADH (vasopressin), serotonin, dopamine, oxytocin, prolactin and indirectly ...
Fulya Özgün   +3 more
doaj  

Treatment of Canine Atopic Dermatitis: Updated Guidelines From the International Committee on Allergic Diseases of Animals (ICADA)

open access: yesVeterinary Dermatology, Volume 37, Issue 6, Page 963-989, December 2026.
ABSTRACT Background Canine atopic dermatitis (cAD) is a genetically, aetiologically, immunologically and clinically complex disease requiring both individualised immediate and long‐term management. Objectives These updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA) aim to substantially revise previous ...
Ralf S. Mueller   +4 more
wiley   +1 more source

Psychogenic polydipsia in bipolar affective disorder — A case report

open access: yes, 2011
Polydipsia is a less examined but prevalent condition in patients with psychiatric disorders. It is usually described in schizophrenia but is rarely reported in bipolar affective disorder (BPAD).
Gangadhar, Bangalore N.   +11 more
core   +1 more source

Immune Checkpoint Inhibitor‐Induced Diabetic Ketoacidosis in a Patient With Pre‐Existing Type 2 Diabetes: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Immune checkpoint inhibitors (ICIs) may cause rare life‐threatening ICI‐associated diabetes mellitus. We report a 60‐year‐old Chinese male with pre‐existing type 2 diabetes who developed toripalimab‐induced diabetic ketoacidosis after 3 treatment cycles. He also had toripalimab‐related hyperthyroidism.
Lingfen Zeng, Jieming Sun
wiley   +1 more source

Home - About - Disclaimer - Privacy